Cargando…
The Use of Non-invasive Vagus Nerve Stimulation to Treat Respiratory Symptoms Associated With COVID-19: A Theoretical Hypothesis and Early Clinical Experience
OBJECTIVES: Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a pandemic with no specific therapeutic agents and substantial mortality, and finding new treatments is critical. Most cases are mild, but a significant minority of patients de...
Autores principales: | Staats, Peter, Giannakopoulos, Georgios, Blake, Justyna, Liebler, Eric, Levy, Robert M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Neuromodulation Society. Published by Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7267613/ https://www.ncbi.nlm.nih.gov/pubmed/32342609 http://dx.doi.org/10.1111/ner.13172 |
Ejemplares similares
-
Vagus Nerve Stimulation as a Treatment for Catatonia: A Hypothesis
por: Zilles, David
Publicado: (2019) -
Vagus nerve stimulation: Invasive or noninvasive?
por: Anfinogenova, Yana
Publicado: (2016) -
Non-invasive vagus nerve stimulation for treatment of cluster headache: early UK clinical experience
por: Marin, Juana, et al.
Publicado: (2018) -
Non-invasive Vagus Nerve Stimulation for COVID-19: Results From a Randomized Controlled Trial (SAVIOR I)
por: Tornero, Carlos, et al.
Publicado: (2022) -
Cost-effectiveness analysis of non-invasive vagus nerve stimulation for the treatment of chronic cluster headache
por: Morris, James, et al.
Publicado: (2016)